DAVID CLAY CAMPBELL M.D. NPI 1811100985

NPI Details

David Clay Campbell, M.D. is a family medicine in Guntersville, AL with 19 years of experience. The provider is family Medicine is the medical specialty which is concerned with the total health care of the individual and the family. It is the specialty in breadth which integrates the biological, clinical, and behavioral sciences. The scope of family medicine is not limited by age, sex, organ system, or disease entity. David Clay Campbell, M.D. NPI is 1811100985. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE
Graduation Year:2006

The provider's business location address is:

38 ROWE DR
GUNTERSVILLE, AL
ZIP 35976-367
Phone: (256) 571-8460
Fax: (256) 571-8464

The NPI 1811100985 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Detection test by nucleic acid for organism, amplified probe technique (HCPCS:87798)
• Injection, ceftriaxone sodium, per 250 mg (HCPCS:J0696)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Management using the results of remote vital sign monitoring per calendar month, first 20 minutes (HCPCS:99457)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Detection test for candida species (yeast), amplified probe technique (HCPCS:87481)
• Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS:J3301)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r (HCPCS:U0003)
• Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes (HCPCS:99458)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within (HCPCS:U0005)
• Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique (HCPCS:87640)
• Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days (HCPCS:99454)
• Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg (HCPCS:J0702)
• Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza (HCPCS:87428)
• Automated urinalysis test (HCPCS:81003)
• Detection test by nucleic acid for multiple types of respiratory virus, multiple types or subtypes, 3-5 targets (HCPCS:87631)
• Injection, ketorolac tromethamine, per 15 mg (HCPCS:J1885)
• Detection test by nucleic acid for mycoplasma pneumoniae (bacteria), amplified probe technique (HCPCS:87581)
• Detection test by nucleic acid for chlamydia pneumoniae, amplified probe technique (HCPCS:87486)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique (HCPCS:87500)
• Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage (HCPCS:90694)
• Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique (HCPCS:87653)
• Detection test by nucleic acid for multiple organisms, amplified probe(s) technique (HCPCS:87801)
• X-ray of chest, 2 views (HCPCS:71046)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a (HCPCS:G0179)
• Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment (HCPCS:99453)
• Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report (HCPCS:93000)
• Fee covid-19 vac 13 res (HCPCS:0124A)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
• Injection, orphenadrine citrate, up to 60 mg (HCPCS:J2360)
• Adm sarscov2 30mcg/0.3ml 3rd (HCPCS:0003A)
• Ultrasound of heart with color-depicted blood flow, rate, direction and valve function (HCPCS:93306)
• Ultrasound study of one arm or leg veins with compression and maneuvers (HCPCS:93971)
• Administration of pneumococcal vaccine (HCPCS:G0009)
• Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or (HCPCS:G2212)
• Adm sarscov2 30mcg/0.3ml bst (HCPCS:0004A)
• Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus (HCPCS:87426)
• Detection test by immunoassay with direct visual observation for influenza virus (HCPCS:87804)
• Injection, lincomycin hcl, up to 300 mg (HCPCS:J2010)
• Ultrasound of both sides of head and neck blood flow (HCPCS:93880)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Ultrasound study of arm or leg veins with compression and maneuvers (HCPCS:93970)
• X-ray of lower and sacral spine, 2-3 views (HCPCS:72100)
• X-ray of knee, 3 views (HCPCS:73562)
• Influenza vaccine, quadrivalent, 0.5 ml dosage (HCPCS:90688)
• Removal of impacted ear wax (HCPCS:69210)
• Blood glucose (sugar) test performed by hand-held instrument (HCPCS:82962)
• Complete ultrasound scan of abdomen (HCPCS:76700)
• Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use (HCPCS:90677)
• Intravenous injection, bebtelovimab, includes injection and post administration monitoring (HCPCS:M0222)
• X-ray of abdomen, 2 views (HCPCS:74019)
• Ultrasound scan of head and neck soft tissue (HCPCS:76536)
• X-ray of hip, 2-3 views (HCPCS:73502)
• Ultrasound of leg arteries or artery grafts (HCPCS:93925)
• Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring (HCPCS:M0243)
• Administration of vaccine (HCPCS:90471)
• X-ray of foot, minimum of 3 views (HCPCS:73630)
• X-ray of shoulder, minimum of 2 views (HCPCS:73030)
• X-ray of ribs on side of body, minimum of 3 views (HCPCS:71101)
• Pneumococcal vaccine, 23-valent (HCPCS:90732)
• Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) (HCPCS:87880)

The enumeration date for this NPI number is 5/7/2007 and was last updated on 2/24/2020.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available: